Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|December 11, 2014
Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunctionJames M Stevenson, Jeffrey R Bishop
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response OutcomesIlia Rattsev, James M Stevenson, Casey Overby Taylor
Clinical and Translational Science|February 18, 2026
A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response OutcomesIlia Rattsev, James M Stevenson, Casey Overby Taylor
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 28, 2023
Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete resultsJohn Loftus, Howard P Levy, James M Stevenson
American Journal of Alzheimer'S Disease and Other Dementias|May 9, 2020
Risk Factors for Cardiovascular Events in Patients on Antidementia MedicationsMeiqi He, James M Stevenson, Yuting Zhang, et al.
Pharmacogenetics and Genomics|October 13, 2023
Pharmacogenetics to prevent hypersensitivity reactions to antiepileptic drugs: is testing performed when indicated?Vy L Bui, Santiago Alvarez-Arango, James M Stevenson
Pharmacogenomics|March 20, 2025
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testingMichele Cung, John Loftus, Mark A Marzinke, et al.
Clinical and Translational Science|October 21, 2020
Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United StatesJames M Stevenson, G Caleb Alexander, Natasha Palamuttam, et al.
Pageof 4